MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • Politics
  • Opinion
  • World
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Neuralink

  • US Investigating Elon Musk’s Neuralink Over Hazardous Pathogens
    US Investigating Elon Musk’s Neuralink Over Hazardous Pathogens
    The U.S. Department of Transportation said on Thursday it is investigating Elon Musk's brain-implant company Neuralink over the potentially illegal movement of hazardous pathogens. A Department of Transportation spokesperson told ...
    February 10, 2023BY Reuters
  • Musk’s Neuralink
    Musk’s Neuralink
    Friend or Foe?
  • Musk’s Neuralink Promising for Disabled, ‘Ethical Concern’ for Masses, Experts Say
    Musk’s Neuralink Promising for Disabled, ‘Ethical Concern’ for Masses, Experts Say
    The Neuralink implant that aims to allow a person to control a computer with thoughts has good potential ...
    December 21, 2022BY Petr Svab
  • Gates, Bezos Invest in Australian-Designed Brain Implant
    Gates, Bezos Invest in Australian-Designed Brain Implant
    Billionaires Bill Gates and Jeff Bezos are betting on the New York-based Synchron as the answer to Elon ...
    December 16, 2022BY Daniel Y. Teng
  • Elon Musk’s Brain Implant Startup Neuralink Holds ‘Show and Tell’ Recruitment Drive
    Elon Musk’s Brain Implant Startup Neuralink Holds ‘Show and Tell’ Recruitment Drive
    Elon Musk's neurotechnology company Neuralink hosted a "show and tell" on Wednesday aimed at recruiting new talent. The ...
    December 1, 2022BY Katabella Roberts
  • Is the US Government Creating Brain Hacking Technology?
    Is the US Government Creating Brain Hacking Technology?
    Commentary In July 2016, the new CEO of Twitter, Elon Musk, launched Neuralink, a neurotechnology company specializing in ...
    November 29, 2022BY John Mac Ghlionn
  • Neuralink’s ‘Show & Tell’ Delayed by One Month, Elon Musk Says
    Neuralink’s ‘Show & Tell’ Delayed by One Month, Elon Musk Says
    Billionaire Elon Musk said in a tweet on Sunday pushed back by a month the date for Neuralink's ...
    October 25, 2022BY Reuters
  • Elon Musk’s Brain-Chip Company Neuralink Gets Overtaken in US by Australian Startup
    Elon Musk’s Brain-Chip Company Neuralink Gets Overtaken in US by Australian Startup
    Australia-based startup Synchron planted its fifth brain-computer device and the first into the brain of a U.S. patient, emerging as ...
    July 20, 2022BY Benzinga
TOP NEWS
  • New York Close to Passing Statewide Gas Stove Ban on New Homes
    3hr By Bill Pan
    New York Close to Passing Statewide Gas Stove Ban on New Homes
  • Kidney Disease: A Silent Killer With 7 Early Symptoms to Consider
    4hr By Teresa Zhang
    Kidney Disease: A Silent Killer With 7 Early Symptoms to Consider
  • Many Americans Likely in for Tax Refund Disappointment: Survey
    4hr By Jack Phillips
    Many Americans Likely in for Tax Refund Disappointment: Survey
  • Philadelphia Officials Issue Emergency Alert to Residents to Drink Bottled Water After Chemical Spill
    6hr By Jack Phillips
    Philadelphia Officials Issue Emergency Alert to Residents to Drink Bottled Water After Chemical Spill
  • Putin Says Russia Will Place Tactical Nuclear Weapons in Neighboring Country
    7hr By Jack Phillips
    Putin Says Russia Will Place Tactical Nuclear Weapons in Neighboring Country
  • Law Professor Reveals Why Manhattan DA’s Case Against Trump Is ‘Falling Apart’
    8hr By Jack Phillips
    Law Professor Reveals Why Manhattan DA’s Case Against Trump Is ‘Falling Apart’
  • Architecture: Sanctuary of a Prussian King: Germany’s Palace of Sanssouci
    8hr By Ariane Triebswetter
    Architecture: Sanctuary of a Prussian King: Germany’s Palace of Sanssouci
  • Man Plagued by Depression, Considering Suicide, Until A Miraculous Book Changed Everything
    10hr By Lisa Bian and Angela Bright
    Man Plagued by Depression, Considering Suicide, Until A Miraculous Book Changed Everything
  • Federal ‘Major Disaster’ Declared in Mississippi After Dozens Killed by Tornadoes
    11hr By Jack Phillips
    Federal ‘Major Disaster’ Declared in Mississippi After Dozens Killed by Tornadoes
  • Trump Suggests Manhattan DA’s Office ‘Dropped’ Case Against Him
    11hr By Jack Phillips
    Trump Suggests Manhattan DA’s Office ‘Dropped’ Case Against Him
The Epoch Times
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
You deserve to hear the truth.
  • Contact Us
  • Media Statements
  • About Us
  • RSS Feeds
  • Terms of Services
  • Privacy Policy
  • Copyright Policy
  • Data Disclaimer
  • Digital Newspaper
  • Our Story
  • Subscribe
  • Careers
36 COUNTRIES, 22 LANGUAGES
  • Bulgarian
  • English
  • Chinese
  • Spanish
  • Japanese
  • Korean
  • Indonesian
  • French
  • German
  • Greek
  • Italian
  • Portuguese
  • Swedish
  • Dutch
  • Russian
  • Ukrainian
  • Romanian
  • Czech
  • Slovak
  • Polish
  • Turkish
  • Persian
  • Vietnamese
DOWNLOAD OUR APP
iOS Android
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
Copyright © 2000 - 2023 The Epoch Times Association Inc. All Rights Reserved.
Back Top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Use. More informationI accept×